Title: Association between cumulative uric acid exposure and metabolic dysfunction-associated
fatty liver disease
Version: 2 Date: 11 Mar 2025
Reviewer's report:
The revision is somewhat better than the first version but still inadequate to be
recommended for publication. Authors neglected important reseacrh linking serum uric
acid to metabolic and inflammatory disorders such as hypertension (Postgraduate Medicine
2022;134(3): 297-302. DOI: 10.1080/00325481.2022.2039007), hepatosteatosis (Rev Assoc
Med Bras 2021;67(4):549-554. DOI: 10.1590/1806-9282.20201005.), type 2 DM (Aging Male.
2020;23(5):1098-1102. DOI: 10.1080/13685538.2019.1678126), thyroiditis (Rom. J. Intern.
Med. 2021;59(4):403-408. DOI: 10.2478/rjim-2021-0023.), metabolic syndrome (Rev Assoc
Med Bras 2019; 65(1):9-15.  DOI: 10.1590/1806-9282.65.1.9), prediabetes (Bratisl Med J
2024;125(3): 145–148. DOI: 10.4149/BLL_2023_130.),  diabetic kidney disease (Postgraduate
Medicine 2023;135(5):519-523. DOI:10.1080/00325481.2023.2214058), and even new onset
diabetes (Acta Clin Croat 2023;62:277-282. doi: 10.20471/acc.2023.62.02.04.).  Discuss please.
Other parts of the revised file is ok.
Title: Association between cumulative uric acid exposure and metabolic dysfunction-associated
fatty liver disease
Version: 2 Date: 11 Mar 2025
Reviewer's report:
The revision is somewhat better than the first version but still inadequate to be
recommended for publication. Authors neglected important reseacrh linking serum uric
acid to metabolic and inflammatory disorders such as hypertension (Postgraduate Medicine
2022;134(3): 297-302. DOI: 10.1080/00325481.2022.2039007), hepatosteatosis (Rev Assoc
Med Bras 2021;67(4):549-554. DOI: 10.1590/1806-9282.20201005.), type 2 DM (Aging Male.
2020;23(5):1098-1102. DOI: 10.1080/13685538.2019.1678126), thyroiditis (Rom. J. Intern.
Med. 2021;59(4):403-408. DOI: 10.2478/rjim-2021-0023.), metabolic syndrome (Rev Assoc
Med Bras 2019; 65(1):9-15.  DOI: 10.1590/1806-9282.65.1.9), prediabetes (Bratisl Med J
2024;125(3): 145–148. DOI: 10.4149/BLL_2023_130.),  diabetic kidney disease (Postgraduate
Medicine 2023;135(5):519-523. DOI:10.1080/00325481.2023.2214058), and even new onset
diabetes (Acta Clin Croat 2023;62:277-282. doi: 10.20471/acc.2023.62.02.04.).  Discuss please.
Other parts of the revised file is ok.
Please review this paper.
user
Title: Association between cumulative uric acid exposure and metabolic dysfunction-associated
fatty liver disease
Version: 2 Date: 11 Mar 2025
Reviewer's report:
The revision is somewhat better than the first version but still inadequate to be
recommended for publication. Authors neglected important reseacrh linking serum uric
acid to metabolic and inflammatory disorders such as hypertension (Postgraduate Medicine
2022;134(3): 297-302. DOI: 10.1080/00325481.2022.2039007), hepatosteatosis (Rev Assoc
Med Bras 2021;67(4):549-554. DOI: 10.1590/1806-9282.20201005.), type 2 DM (Aging Male.
2020;23(5):1098-1102. DOI: 10.1080/13685538.2019.1678126), thyroiditis (Rom. J. Intern.
Med. 2021;59(4):403-408. DOI: 10.2478/rjim-2021-0023.), metabolic syndrome (Rev Assoc
Med Bras 2019; 65(1):9-15.  DOI: 10.1590/1806-9282.65.1.9), prediabetes (Bratisl Med J
2024;125(3): 145–148. DOI: 10.4149/BLL_2023_130.),  diabetic kidney disease (Postgraduate
Medicine 2023;135(5):519-523. DOI:10.1080/00325481.2023.2214058), and even new onset
diabetes (Acta Clin Croat 2023;62:277-282. doi: 10.20471/acc.2023.62.02.04.).  Discuss please.
Other parts of the revised file is ok.
assistant